Assignee
ZEVRA DENMARK AS
DK·2 granted patents·7 pending applications·1 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0187US11938125B2Use of Hsp70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2022·Granted Mar 26, 2024·1 cites·5 claims
- 0284US12576076B2Use of HSP70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2024·Granted Mar 17, 2026·0 cites·9 claims
- 0371US2025387384A1Arimoclomol for treating glucocerebrosidase associated disordersZEVRA DENMARK AS·Filed 2025·Application pending·0 cites
- 0466US2024024306A1Processes for preparing arimoclomol citrate and intermediates thereofZEVRA DENMARK AS·Filed 2023·Application pending·0 cites
- 0560US2023416224A1Processes for preparing arimoclomol citrate and intermediates thereofZEVRA DENMARK AS·Filed 2021·Application pending·0 cites
- 0652US2024390383A1Dioxazines and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0752US2024390357A1Pyridines and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0852US2024383853A1Oximes and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0945US2024115558A1Arimoclomol for the treatment of niemann pick disease, type c, in patients with er type missense mutationsZEVRA DENMARK AS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZEVRA DENMARK AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →